Topiramate in add-on therapy: Results from an open-label, observational study

Seizure

Volumn 16, Issue 7, 2007, Pages 593-600

  Krakow, K ^a   Lengler, U ^a   Rettig, K ^b   Schreiner, A ^c   Schauble, B ^c  

^a GOETHE UNIVERSITY   (Germany)

^b GEM   (Germany)

^c Janssen Cilag EMEA ^*  (Germany)

Author keywords

Add on therapy; Anticonvulsive drugs; Broad spectrum anticonvulsant; Epilepsy; Topiramate

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENYTOIN; PRIMIDONE; PSYCHOTROPIC AGENT; TOPIRAMATE; VALPROIC ACID;

ADD ON THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; DEPRESSION; DIZZINESS; DRUG DOSE ESCALATION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EPILEPSY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MONOTHERAPY; MULTICENTER STUDY; NAUSEA; OBSERVATIONAL STUDY; OPEN STUDY; PARESTHESIA; PERCEPTION DISORDER; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SIDE EFFECT; SKIN DISEASE; SOMNOLENCE; SPEECH DISORDER; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; BODY WEIGHT; CHILD; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; ENDPOINT DETERMINATION; EPILEPSY; FEMALE; FRUCTOSE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEIZURES; TREATMENT OUTCOME;

EID: 34548180860     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2007.04.007     Document Type: Article

References (11)

1. Beydoun A. Monotherapy trials of new antiepileptic drugs. Epilepsia 38 Suppl. 9 (1997) S21-S31
2. Brodie M.J., Richens A., and Yuen A.W. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Lancet 345 (1995) 476-479
3. Kwan P., and Brodie M.J. Early identification of refractory epilepsy. N Engl J Med 342 (2000) 314-319
4. Herrero A.I., Del O.N., Gonzalez-Escalada J.R., and Solis J.M. Two new actions of topiramate: inhibition of depolarizing GABA(A)-mediated responses and activation of a potassium conductance. Neuropharmacology 42 (2002) 210-220
5. Waugh J., and Goa K.L. Topiramate: as monotherapy in newly diagnosed epilepsy. CNS Drugs 17 (2003) 985-992
6. Bialer M., Doose D.R., Murthy B., Curtin C., Wang S.S., Twyman R.E., et al. Pharmacokinetic interactions of topiramate. Clin Pharmacokinet 43 (2004) 763-780
7. Reife R., Pledger G., and Wu S.C. Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults. Epilepsia 41 Suppl 1 (2000) S66-S71
8. Cramer J.A., Fisher R., Ben-Menachem E., French J., and Mattson R.H. New antiepileptic drugs: comparison of key clinical trials. Epilepsia 40 (1999) 590-600
9. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1989; 30:389-99.
10. Guberman A., Neto W., and Gassmann-Mayer C. Low-dose topiramate in adults with treatment-resistant partial-onset seizures. Acta Neurol Scand 106 (2002) 183-189
11. Peeters K., Adriaenssen I., Wapenaar R., Neto W., and Pledger G. A pooled analysis of adjunctive topiramate in refractory partial epilepsy. Acta Neurol Scand 108 (2003) 9-15